Shareholder Alert: Robbins LLP Is Investigating the Officers & Directors of Sage Therapeutics, Inc. (SAGE) on Behalf of Share...
November 25 2019 - 6:44PM
Business Wire
Shareholder rights law firm Robbins LLP is investigating whether
certain officers and directors of Sage Therapeutics, Inc. (NASDAQ:
SAGE) breached their fiduciary duties to shareholders. Sage
Therapeutics is a clinical-stage biopharmaceutical company that
develops and commercializes medicines to treat central nervous
system (CNS) disorders.
If you suffered a loss as a result of Sage Therapeutics'
misconduct, click here.
Sage Therapeutics, Inc. (SAGE) Shareholders Have Legal
Options
Contact us to learn more: Leonid Kandinov (800) 350-6003
LKandinov@robbinsllp.com Shareholder Information Form
Robbins LLP is a nationally recognized leader in shareholder
rights law. The firm represents individual and institutional
investors in shareholder derivative and securities class action
lawsuits, and has helped its clients realize more than $1 billion
of value for themselves and the companies in which they have
invested. Click here to receive free alerts from Stock Watch when
companies engage in wrongdoing.
Attorney Advertising. Past results do not guarantee a similar
outcome.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191125005858/en/
Leonid Kandinov Robbins LLP 5040 Shoreham Place San Diego, CA
92122 LKandinov@robbinsllp.com (619) 525-3990 or Toll Free (800)
350-6003 www.robbinsllp.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2023 to Sep 2024